MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-31-0003476
Bengene Life Sciences Private Limited - pharma in Villupuram, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹5.14 Cr
▲ 32% YoY
Net loss · FY 2025
₹45.14 Lakh
Net margin -8.8%
EBITDA · FY 2025
₹22.65 Lakh
EBITDA margin 4.4%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹97 Lakh
Issued & subscribed
Open charges
₹2.45 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
3
As per MCA filings
About Bengene Life Sciences Private Limited
Data last updated:
Bengene Life Sciences Private Limited is a private limited company based in Villupuram, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24290TN2019PTC127701. Its GSTIN is 33AAICB3032C1ZE (Tamil Nadu).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹97 Lakh. It is led by directors including Ponniah Saravanaperumal and Dhanabal Lakshmanan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Villupuram, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.14 Cr, a growth of 32% compared to the previous year. For the same year it recorded a net loss of ₹45.14 Lakh (net margin -8.8%) and EBITDA of ₹22.65 Lakh (EBITDA margin 4.4%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 40% over five years.
As per MCA filings, the company has open charges of ₹2.45 Cr on record.
Bengene Life Sciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-31-0003476). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bengene.in.
Company Details of Bengene Life Sciences Private Limited
CIN U24290TN2019PTC127701
Registration Number 127701
Incorporation Date 25 February 2019
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TN-31-0003476
Key People
Ponniah Saravanaperumal Director Dhanabal Lakshmanan Director Perumal Shanmugam Additional Director Recognitions & Rankings of Bengene Life Sciences
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressR.S. No: 239/2 Mettupalayam – Manaveli Road Poothurai Village Vanur Taluk Villupur, Am, Villupuram, Tamil Nadu, India – 605111
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Bengene Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Bengene Life Sciences Private Limited
The main business activity of Bengene Life Sciences is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Bengene Life Sciences Private Limited FY 2025 filings available
Bengene Life Sciences Private Limited reported revenue of ₹5.14 Cr (up 32% YoY) for FY 2025.
Revenue · FY 2025
₹5.14 Cr ▲ 32%
Net loss · FY 2025
₹45.14 Lakh margin -8.8%
EBITDA · FY 2025
₹22.65 Lakh margin 4.4%
Compounded Annual Growth Rate (CAGR) of Bengene Life Sciences Private Limited
Revenue CAGR growth
1 year
▲ 32%
3 years · compounded
▼ 2%
5 years · compounded
▲ 40%
EBITDA CAGR growth
1 year
▼ 53%
3 years · compounded
▲ 102%
5 years · compounded
▲ 85%
Revenue has grown at a compounded annual rate (CAGR) of 40% over five years, including 32% growth in the latest year. EBITDA fell 53% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Bengene Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹22.65 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹45.14 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Bengene Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -8.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bengene Life Sciences are in the company report.
Premium access
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Bengene Life Sciences Private Limited
Bengene Life Sciences has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ponniah Saravanaperumal | Director | 25 Feb 2019 | 7 Years 7 Months | Current |
| Dhanabal Lakshmanan | Director | 25 Feb 2019 | 7 Years 7 Months | Current |
| Perumal Shanmugam | Additional Director | 30 Apr 2019 | 7 Years 5 Months | Current |
Peer Comparison of Bengene Life Sciences Private Limited
Bengene Life Sciences Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Other professional, scientific and technical activities). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biourja India Infra Private Limited | ₹5.15 Cr (FY 2025) | •••• | •••• | -54.0% | •••• | Indore, Madhya Pradesh, India |
| Avon Technologies (India) Private Limited | ₹5.15 Cr (FY 2025) | •••• | •••• | 52.0% | •••• | Hyderabad, Telangana, India |
| Vashist Infra Engineering Private Limited | ₹5.15 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | New Delhi, Delhi, India |
| Qualitykiosk Tech Solutions Private Limited | ₹5.15 Cr (FY 2024) | •••• | •••• | -11.0% | •••• | Thane, Maharashtra, India |
| MD IT Network Private Limited | ₹5.14 Cr (FY 2021) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Bengene Life Sciences Private Limited this company | ₹5.14 Cr (FY 2025) | •••• | •••• | 32.0% | •••• | Villupuram, Tamil Nadu, India |
| Cloudberry360 Technologies Private Limited | ₹5.14 Cr (FY 2024) | •••• | •••• | 21.0% | •••• | Bangalore, Karnataka, India |
| Incwert Advisory Private Limited | ₹5.14 Cr (FY 2024) | •••• | •••• | 41.0% | •••• | Gurgaon, Haryana, India |
| Integrated Centre for Consultancy Private Limited | ₹5.14 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | New Delhi, Delhi, India |
| Pandurang Bhagwan Clearing Aghency Pvt Ltd | ₹5.14 Cr (FY 2025) | •••• | •••• | 53.0% | •••• | Mumbai, Maharashtra, India |
| Amnion Biosciences Private Limited | ₹5.14 Cr (FY 2024) | •••• | •••• | -18.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Bengene Life Sciences by revenue in the same principal business activity (Other professional, scientific and technical activities), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Bengene Life Sciences Private Limited
Bengene Life Sciences Private Limited is audited by SRITHAR & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SRITHAR & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Bengene Life Sciences Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Bengene Life Sciences Private Limited
Open charges
₹2.45 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Mar 2025 | Others | ₹1 Cr | Open |
| 20 Mar 2023 | Others | ₹47 Lakh | Open |
| 03 Feb 2022 | Others | ₹98 Lakh | Open |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Bengene Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Bengene Life Sciences.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Bengene Life Sciences Private Limited
Bengene Life Sciences Private Limited has 5 board changes on record since 2019: 4 appointments and 1 cessation. The latest: Senthiladipan Venkatachalam ceased to be Director on 29 Jan 2026.
Ceased
Senthiladipan Venkatachalam ceased to be Director.
AGM
Bengene Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Bengene Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 101086452 was registered on 17 Mar 2025.
Charges
A charge with Others amounted to Rs. 0.47 Cr with Charge ID 100710404 was registered on 20 Mar 2023.
Charges
A charge with Others amounted to Rs. 0.98 Cr with Charge ID 100540359 was registered on 03 Feb 2022.
Appointed
Perumal Shanmugam was appointed as Additional Director.
Appointed
Dhanabal Lakshmanan was appointed as Director.
Appointed
Ponniah Saravanaperumal was appointed as Director.
Appointed
Senthiladipan Venkatachalam was appointed as Director.
Incorporation
25 Feb 2019
Bengene Life Sciences Private Limited was registered on 25 Feb 2019 with Roc Chennai & aged 7 years 7 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Bengene Life Sciences Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bengene Life Sciences Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bengene Life Sciences Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bengene Life Sciences Private Limited
Bengene Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAICB3032C1ZE | Tamil Nadu | Active | 25 Mar 2019 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bengene Life Sciences Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bengene Life Sciences Private Limited
Bengene Life Sciences is an active private limited company based in Villupuram, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 February 2019 (7+ years old) and is registered under CIN U24290TN2019PTC127701.
Bengene Life Sciences reported revenue of ₹5.14 Cr for FY 2025 (up 32% YoY).
Bengene Life Sciences has 3 current directors:
- Ponniah Saravanaperumal - Director
- Dhanabal Lakshmanan - Director
- Perumal Shanmugam - Additional Director
Bengene Life Sciences reported a net loss of ₹45.14 Lakh (net margin -8.8%) and EBITDA of ₹22.65 Lakh (EBITDA margin 4.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Bengene Life Sciences is -2% over three years and 40% over five years. In the latest year (FY 2025) revenue rose 32%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Bengene Life Sciences is 33AAICB3032C1ZE, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Bengene Life Sciences is U24290TN2019PTC127701. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bengene Life Sciences was incorporated on 25 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Bengene Life Sciences by revenue are Biourja India Infra Private Limited, Avon Technologies (India) Private Limited, Vashist Infra Engineering Private Limited, Qualitykiosk Tech Solutions Private Limited, MD IT Network Private Limited and 5 more, all in the same principal business activity (Other professional, scientific and technical activities).
Senthiladipan Venkatachalam ceased to be Director on 29 Jan 2026. Perumal Shanmugam was appointed as Additional Director on 30 Apr 2019. Dhanabal Lakshmanan was appointed as Director on 25 Feb 2019. Bengene Life Sciences has 5 board changes on record in total.
Yes, Bengene Life Sciences is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-31-0003476).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, charges, legal cases and filings.
Tata Steel Limited Listed company · 91 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 42 pages